MannKind Corporation (NASDAQ: MNKD) is headed up in the premarket hours this morning, and for good reason. The company announced that the FDA has accepted a New Drug Application for priority review. Here’s what’s happening: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! MNKD Heads Up On Priority Review Acceptance … Read more
MannKind Corporation (NASDAQ: MNKD) is catching the attention of investors this morning after announcing the approval of Affrezza in Brazil. As a result of the approval, the stock is up more than 6% in the pre-market as excited investors snap up shares. Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! … Read more
MannKind Corporation (NASDAQ: MNKD) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The comapny announced a new distribution agreement, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The distribution agreement; what we’re seeing from MNKD stock as a result; … Read more
MannKind Corporation (NASDAQ: MNKD) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it has received a milestone payment, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The milestone payment; what we’re seeing from MNKD stock … Read more
MannKind Corporation (NASDAQ: MNKD) is having a great day in the market today. However, if you’re digging for the reason, you’re not going to find it on Yahoo! Finance News or through SEC filings. Nonetheless, there’s a good reason for the gains. Today, MNKD is in the center of two analyst coverage initiations. Both of … Read more
MannKind Corporation (NASDAQ: MNKD) is running up in the market again this morning as investor excitement continues to run high. So, what’s the deal? Why are investors so excited? Today, we’ll talk about: Why investors are so excited about MNKD stock; what we’re seeing in the market; and what we’ll be watching for ahead. Why … Read more
MannKind Corporation (NASDAQ: MNKD) is having an relatively strong start to the trading session this morning, and for good reason. The company announced that it has closed a key licesning and collaboration agreement surrounding Technosphere. Of course, the news excited investors who are pushing the stock upward. Today, we’ll talk about: The agreement; what we’re … Read more
MannKind Corporation (NASDAQ: MNKD) is having yet another incredibly strong start to the trading session this morning, and for good reason. It seems as though after the positive news released last week, investor confidence is soaring and the company has the opportunity to see incredible growth ahead. Today, we’ll talk about: Why the gains may … Read more
MannKind Corporation (NASDAQ: MNKD) is dipping a bit in the market after a multi-session gain more than doubled the value of the stock from Tuesday through Wednesday. With the dip in mind, some are starting to wonder if now is the time to invest in the stock. Today, we’ll talk about: Why the stock had … Read more
MannKind Corporation (NASDAQ: MNKD) is having a great start to the trading session this morning, following up on the gains felt yesterday. Early yesterday, we covered the reason for the gains. Essentially, the company entered into an agreement with United Therapeutics that’s worth about $95 million. But, the stock is is trading at around double … Read more